The landscape of dementia prognosis has developed drastically with the arrival of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-primarily based assessments that can detect Alzheimer's pathology several years before indicators arise. While these technological improvements stand for outstanding development in understand